Oroxylin A-induced SOD2 activity inhibition and increased ROS were

LUNG POWER 200:1 New!, Interstellar Blends

Redox Paradox: A Novel Approach to Therapeutics-Resistant Cancer. - Abstract - Europe PMC

Chen QIAO, Xi'an Jiaotong University, Xi'an, XJTU, Department of Automation Science and Technology

Antioxidants, Free Full-Text

Redox Regulation of Cell Survival

Oroxylin A inhibits glycolysis-dependent proliferation of human breast cancer via promoting SIRT3-mediated SOD2 transcription and HIF1α destabilization

Polyphyllin VII Promotes Apoptosis and Autophagic Cell Death via ROS-Inhibited AKT Activity, and Sensitizes Glioma Cells to Temozolomide

PDF) Oroxylin A modulates mitochondrial function and apoptosis in human colon cancer cells by inducing mitochondrial translocation of wild-type p53

Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target. - Abstract - Europe PMC

Anticancer potential of oroxylin A: from mechanistic insight to synergistic perspectives

Luteolin blocks the ROS/PI3K/AKT pathway to inhibit mesothelial-mesenchymal transition and reduce abdominal adhesions - ScienceDirect

Oroxylin A suppress LL-37 generated rosacea-like skin inflammation through the modulation of SIRT3-SOD2-NF-κB signaling pathway - ScienceDirect